Can Pharma Rebuild Its Reputation? COVID-19 Means A Big Responsibility, And Opportunity

 
• By Jessica Merrill
reputation management concept
COVID-19 presents a rare chance for pharma to improve its rating by the public • Source: Shutterstock

More from COVID-19

More from Scrip